Skip to main content
Equibles

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in VCYT — Veracyte, Inc.

CIK 1177206 LOS ANGELES, CA
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,086,727
+$1,142,701 QoQ
Shares Held
69,585
-23.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 367 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 45% Shared 0% None 55%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $124,148,206 across 27 Diagnostics & Research names. VCYT ranks #6 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 477,841 $63,471,620
2 IQV
Iqvia Holdings Inc.
 131,127 $25,336,358
3 NTRA
Natera, Inc.
 48,046 $13,042,086
4 IDXX
Idexx Laboratories Inc /De
 17,602 $9,266,396
5 MEDP
Medpace Holdings, Inc.
 10,200 $5,401,818
6 VCYT
Veracyte, Inc.
This page 		69,585 $4,086,727
7 TMO
Thermo Fisher Scientific Inc.
 1,631 $817,718
8 GH
Guardant Health, Inc.
 3,578 $536,807

All Filings in VCYT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,086,727 69,585
2026-03-31 $2,944,026 91,401
2025-12-31 $2,317,352 55,044
2025-09-30 $1,894,123 55,174
2025-06-30 $811,251 30,013
2025-03-31 $547,991 18,482
2024-12-31 $766,933 19,367
2024-09-30 $703,266 20,660
2024-06-30 $453,119 20,910
2024-03-31 $463,365 20,910
2023-12-31 $264,288 9,607
2022-06-30 $532,305 26,749
2021-12-31 $245,057 5,948
2021-09-30 $278,932 6,005
2021-06-30 $234,882 5,875
2021-03-31 $331,906 6,175